NeoTract

The decision makers in UroLift® System By Teleflex Interventional Urology are Drew Steeh, John Hines, Larry Caplan, etc. Click to Find UroLift® System By Teleflex Interventional Urology decision makers emails.

The UroLift® System is a minimally invasive medical device designed to treat lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The procedure involves the placement of small implants that lift and hold the enlarged prostate tissue out of the way, relieving pressure on the urethra and improving urine flow. This outpatient procedure typically takes less than an hour and does not require general anesthesia.

The UroLift® procedure is suitable for men experiencing moderate to severe urinary symptoms related to BPH. Ideal candidates are those who prefer a minimally invasive treatment option and wish to avoid more invasive surgeries like transurethral resection of the prostate (TURP). It is important for patients to consult with their urologist to determine if UroLift® is the right choice based on their individual health conditions and symptom severity.

The UroLift® System offers several benefits compared to traditional BPH treatments. These include a minimally invasive approach that typically results in less pain, a quicker recovery time, and a lower risk of complications such as sexual dysfunction. Most patients can return to normal activities within a few days, and many experience significant improvement in urinary symptoms shortly after the procedure.

During the UroLift® procedure, patients are usually given local anesthesia or sedation to ensure comfort. The urologist will use a cystoscope to visualize the prostate and then insert the UroLift® delivery device to place the implants. The procedure generally takes about 30 to 45 minutes, and patients are monitored for a short period before being discharged the same day. Post-procedure, some mild discomfort or urinary urgency may occur, but these symptoms typically resolve quickly.

While the UroLift® System is considered safe, some patients may experience side effects, which can include mild pelvic discomfort, urinary urgency, or blood in the urine shortly after the procedure. These symptoms are usually temporary and resolve within a few days. It is important for patients to discuss any concerns with their urologist and follow post-procedure care instructions to minimize risks.

The results of the UroLift® procedure can last for several years, with many patients experiencing sustained improvement in urinary symptoms. Clinical studies have shown that the majority of patients maintain symptom relief for at least two years post-procedure. However, individual results may vary, and some patients may require additional treatment as their condition progresses. Regular follow-ups with a urologist are recommended to monitor symptoms and overall prostate health.